EpiCept crew (Nasdaq and OMX Stockholm Exchange: EPCT) announced today that the Swedish AML Group which comprises the leading hematology experts in Sweden has be be included Ceplene® (histamine dihydrochloride) in its dope entitled "National advisement for examination and care of Acute Myeloid Leukemia in Adults." These guidelines, which were issued earlier this month, advocate for the first time the admittance of Ceplene for AML remission maintenance therapy...

More: - Read the rest here